The Latest

Join us on Tuesday, April 21, at 11:00 AM ET for a joint webinar covering obesity management, weight wellness, and musculoskeletal health. Participate in the online panel discussion of the unmet scientific/clinical needs and future directions. Register now!

Medical students and residents now have the opportunity to learn more about endocrinology during our annual meeting, through Endocrine Mentor Day. Participants will have opportunities to connect with leading endocrinologists across a broad range of specialties and practice settings during ENDO 2026, taking place June 13–16 in Chicago, IL. Learn more.

Endocrine Self-Assessment (ESAP) 2026 delivers one hundred twenty new case-based questions that reflect real clinical practice and strengthen judgment. The program includes a comprehensive book, online learning, and a mobile app for flexible study. Earn up to 40 CME and MOC credits with expert authored, rigorously reviewed content. Start this year’s cases today and advance your practice.

The Grant Aims Accelerator Program pairs an early career professional with an experienced mentor to review the mentee’s Specific Aims draft (or international Specific Aims equivalent) for grant proposals. Exclusive to Endocrine Society members, mentors and mentees will be matched by research interests and will meet informally at the ENDO 2026 to discuss how the specific aims draft can be improved. Register for ENDO and sign up by Monday, May 4.

Host Aaron Lohr talks with Sara R. MacLeod, DO, MPH, of the University of Rochester; and Shannon K. Idzik, DNP, CRNP, ANP-BC, FAANP, FAAN, of the University of Maryland School of Nursing, about the recently established Endocrinology Certificate for Advanced Practice Providers.

Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Andy Crawford, MD, from Dartmouth-Hitchcock Medical Center, and guest expert Giuseppe Barbesino, MD, from Harvard Medical School in Boston, about the paper "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease" by Miyamura et al., published in the August 2025 issue of JCEM.